IL-17A inhibitions of indole alkaloids from traditional Chinese medicine Qing Dai.

Authors:
Lee CL; Wang CM; Kuo YH; Yen HR; Song YC and 2 more

Journal:
J Ethnopharmacol

Publication Year: 2020

DOI:
10.1016/j.jep.2020.112772

PMCID:
PMC7156250

PMID:
32194230

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Ethnopharmacol

Abbreviation: J Ethnopharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Social Sciences

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Comparison study of Beninese and Chinese herbal medicines in treating COVID-19.
Houeze EA; Wang Y; Zhou Q and 2 more (2023) - Transparency Score: 4/6
Chemical profiling and unraveling of anti-COVID-19 biomarkers of red sage (Lantana camara L.) culti…
Darwish RS; El-Banna AA; Ghareeb DA and 3 more (2022) - Transparency Score: 2/6
Efficacy and safety of add-on Viola odorata L. in the treatment of COVID-19: A randomized double-bl…
Adel Mehraban MS; Shirzad M; Mohammad Taghizadeh Kashani L and 5 more (2022) - Transparency Score: 4/6
Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhib…
Zhu Y; Han Q; Wang L and 10 more (2022) - Transparency Score: 4/6
Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB …
Cai J; Wang YL; Sheng XD and 2 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare no conflict of interest."

Evidence found in paper:

"This work was financially supported by the “Chinese Medicine Research Center, China Medical University” from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan (CMRC-CHM-2-1). The authors deeply appreciated to Sheng Chang Pharmaceutical Co., Ltd to offer authentic materials for this research."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025